AVRICORE HEALTH INC. Increase Decrease Through Exercise Of Warrants Equity
AVRICORE HEALTH INC. reported Increase Decrease Through Exercise Of Warrants Equity of CAD 173.88 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2025-06-16.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2025-06-16
- AVRICORE HEALTH INC. increase decrease through exercise of warrants equity for the quarter ending 2022-12-31 was 149.88K CAD.
- AVRICORE HEALTH INC. increase decrease through exercise of warrants equity for the quarter ending 2022-09-30 was 0.00 CAD.
| Period end | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 9 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|---|
| 2022-12-31 | 149.88K CAD derived: 20-F 12 month − 6-K 9 month · filed 2025-06-16 | 149.88K CAD derived: sum of 2 quarters · filed 2025-06-16 | 173.88K CAD 20-F · filed 2025-06-16 | |
| 2022-09-30 | 0.00 CAD derived: 6-K 9 month − 6-K 6 month · filed 2023-12-06 | 24.00K CAD 6-K · filed 2023-12-06 | ||
| 2022-06-30 | 24.00K CAD 6-K · filed 2023-09-13 | |||
| 2021-12-31 | 1.65M CAD 20-F · filed 2024-06-12 | |||
| 2018-12-31 | 595.10K CAD 20-F · filed 2021-06-23 | |||
| 2017-12-31 | 454.80K CAD 20-F · filed 2020-12-08 | |||
| 2016-12-31 | 169.00K CAD 20-F · filed 2019-06-17 | |||
| 2015-12-31 | 434.03K CAD 20-F · filed 2018-06-19 | |||
| 2015-06-30 | 2.87M CAD 20-F · filed 2018-06-19 |